Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 30  •  04:00PM ET
37.37
Dollar change
-0.70
Percentage change
-1.85
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y59.36% Total Holdings38 Perf Week-4.57%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM96.61M Perf Month-1.43%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter25.67%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High39.60 -5.64% Perf Half Y51.54%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 98.98% Perf YTD59.76%
Active/Passive Quant Type Tagsmedical Flows% 1M4.59% Volatility2.87% 1.86% Perf Year42.69%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M8.12% ATR (14)0.95 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD16.46% RSI (14)49.74 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.35 Perf 10Y-
Expense0.54% Growth/Value SMA20-2.56% Flows% 3Y Rel Volume0.86 Prev Close38.07
Inverse/Leveraged Market Cap SMA505.69% Flows% 5Y Avg Volume5.68K Price37.37
IPOOct 31, 2024 Option/ShortNo / Yes SMA20035.49% Trades Volume4,893 Change-1.85%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.